Okey Stephanie (CIK 1742616) reported 14 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-01). Recent activity: Sell CRNX (6,400 shares), Sell CRNX (5,925 shares), Buy CRNX (5,925 shares), Sell CRNX (6,292 shares), Sell CRNX (608 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Sell | 6,400 | $544,000 |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Sell | 5,925 | $503,625 |
| 2026-06-22 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Buy | 5,925 | $0 |
| 2026-06-18 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Sell | 6,292 | $224,121 |
| 2026-06-18 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Sell | 608 | $22,022 |
| 2026-03-12 | PTC THERAPEUTICS, INC. (PTCT) | Director | Buy | 1,167 | $39,246 |
| 2026-03-12 | PTC THERAPEUTICS, INC. (PTCT) | Director | Sell | 1,167 | $81,690 |
| 2026-03-12 | PTC THERAPEUTICS, INC. (PTCT) | Director | Buy | 14,000 | $470,820 |
| 2026-03-12 | PTC THERAPEUTICS, INC. (PTCT) | Director | Sell | 14,000 | $980,000 |
| 2026-03-09 | PTC THERAPEUTICS, INC. (PTCT) | Director | Sell | 6,333 | $401,386 |
| 2026-03-04 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Sell | 3,000 | $119,010 |
| 2026-01-06 | PTC THERAPEUTICS, INC. (PTCT) | Director | Buy | 4,000 | $0 |
| 2025-11-21 | PTC THERAPEUTICS, INC. (PTCT) | Director | Sell | 867 | $0 |
| 2025-06-13 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Buy | 6,900 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01